Breaking AI & Tech News Analyzed

World Health Organization Director-General Tedros Adhanom Ghebreyesu confirmed on 31 May 2026 that five individuals infected with the rare Bundibugyo Ebola strain have recovered, including four who will be discharged today and one who left the hospital on Friday. The announcement came as the WHO opened a new treatment centre in Bunia, Ituri province, DRC.First Recoveries Confirmed in Bundibugyo Ebola OutbreakThe recoveries represent the first documented successes against a strain that has no approved vaccine or specific therapy. Doctors Without Borders (MSF) had described the situation as “deeply alarming” due to rapid case growth and diagnostic challenges.Outbreak Statistics Highlight Ongoing ThreatSuspected cases: ~1,000Suspected deaths: >220Current confirmed cases in DRC: rising rapidly across Ituri provinceCross‑border impact: Uganda reports 1 death and 9 casesThe Bundibugyo strain historically carries a case‑fatality rate of up to 50%, intensifying concerns about containment.Health System Strain and Regional Risks IntensifyLimited testing capacity and the absence of approved medical countermeasures have stretched local health infrastructure. MSF warned that the response has not yet caught up with the epidemic’s speed, and the outbreak’s proximity to the Ugandan border raises the risk of cross‑border transmission.Outlook: Vaccine Development and Containment ProspectsWhile the recoveries provide a morale boost, experts stress that sustainable control will depend on accelerated vaccine research, expanded diagnostic capacity, and coordinated regional surveillance. The WHO’s new treatment centre aims to improve patient outcomes, but long‑term containment will require international funding and rapid deployment of experimental therapeutics.

The LeadA daily pill has shown remarkable results in doubling survival time for patients with pancreatic cancer, the world's deadliest form of the disease. According to clinical trial results presented at the American Society of Clinical Oncology's annual meeting, this breakthrough treatment represents a potential revolution in how we approach a cancer that has seen limited progress for decades.The Breakthrough Drug: DaraxonrasibThe drug in question, daraxonrasib, works by targeting a protein called Kras that fuels nearly all pancreatic cancers. This mechanism represents a significant advancement in treatment strategy, as Kras has been notoriously difficult to target effectively. The drug functions as a Ras(On) multi-selective inhibitor, capable of turning off the Kras protein to stop cancer growth regardless of which variant is present.Impressive Trial ResultsIn the clinical trial involving 500 patients with advanced pancreatic cancer, the results were striking. Those who took daraxonrasib lived an average of 13.2 months, compared to just 6.6 to 6.7 months for patients who received chemotherapy. This represents a near doubling of survival time, with the added benefit of fewer side effects compared to traditional chemotherapy treatments.Industry Impact and Expert ReactionsThe findings have been hailed as a "gamechanger" and "grand slam" by experts in the field. Dr. Rachna Shroff, chief of oncology at the University of Arizona Cancer Center, described the results as "landscape-changing" and "unprecedented survival." When she first read the trial results, conducted by researchers at the Dana-Farber Cancer Institute in Boston, she wept, noting the profound impact this could have on patients after 16 years of treating pancreatic cancer.Dr. Julie Gralow, Asco's chief medical officer, echoed these sentiments, calling the study a "home run" and suggesting it was actually a "grand slam" in terms of its significance.The Ras RevolutionOver 90% of patients with the most common form of pancreatic cancer, pancreatic ductal adenocarcinoma (mPDAC), have a mutation in the Kras gene. This discovery has long been considered the "holy grail" in cancer research, particularly for pancreatic cancer where the mutation is nearly ubiquitous and an early driver of cancer growth.Paula Hanford, chief executive of UK-based Pancreatic Cancer Action, called this one of the most significant developments in treatment she had ever seen. Similarly, Anna Jewell, director of services, research and innovation at Pancreatic Cancer UK, described the results as "exciting," noting that the drug gives patients "months more precious time with their loved ones."Future Outlook and ApplicationsThe success of daraxonrasib opens doors for similar treatments targeting Ras genes in other cancers. Experts at the conference noted that because Ras genes fuel various types of cancer, there is hope for breakthroughs in treating lung and colon cancers as well, with similar drugs already in development for these conditions.However, challenges remain in ensuring these promising treatments become widely available to patients. As Jewell pointed out, tragically half of all people with pancreatic cancer die within just three months of diagnosis, making the rapid implementation of such treatments crucial.

The Schreiber family, presiding over a nationwide commercial portfolio via the Midos Group, is at the center of a growing controversy involving two distinct business models: aggressive tax avoidance and the profiteering from the UK's housing crisis. The Dual Nature of the Schreiber Business Empire The investigation reveals a complex web of family-owned entities that appear to operate on opposite ends of the social spectrum. On one side, the Midos Group is accused of exploiting a controversial tax scheme to avoid business rates on empty commercial properties. On the other, a similarly named but ostensibly separate entity, Midos Management Co, is profiting from the UK's chronic shortage of social housing by arranging temporary accommodation for homeless residents. Midos Group: Accused of using the 'faith room' scheme to avoid rates on empty units. Midos Management Co: Collecting fees for arranging temporary accommodation for councils. Key Figures: David Schreiber (Midos Group) and Elizabeth Endzweig (Midos Management Co). Financial Impact of the 'Faith Room' Tax Loophole The core of the tax avoidance allegations centers on a provision that exempts property owners from paying business rates if the space is made available for religious worship. The 'faith room' scheme, marketed by Verity, allegedly involves minimal activity—such as placing a notice and a staff member reading scripture—to create the appearance of worship. Total Savings: Landlords have saved at least £18m through this scheme. Specific Case: Dover District Council is suing for £1.7m of unpaid tax. Properties Involved: Discovery Park in Kent and a disused pub in Clapham, London. Profiting from the Homelessness Crisis While the family allegedly avoids taxes on empty buildings, they are simultaneously capitalizing on the housing emergency. Midos Management Co acts as an intermediary, matching councils with private landlords to house homeless residents. Despite claims of separation, evidence suggests significant overlap between the two entities. Revenue Collected: At least £43m collected on behalf of landlords since 2019. Client Base: Lambeth council and at least four other councils. Directorship Overlap: Elizabeth Endzweig, daughter of David Schreiber, is a co-director of multiple companies sharing the same address as Midos Group. The Future of UK Property Tax Compliance The revelations highlight a growing tension between private profit and public service obligations. With MPs and councils increasingly scrutinizing these arrangements, the 'faith room' exemption is likely to face tighter regulatory oversight. The case sets a precedent for how closely connected family businesses can be without violating anti-avoidance rules, potentially leading to stricter audits of corporate structures in the property sector.

Premier Group Recruitment entered administration in September with nearly £2.9m of debt, including £647,000 owed to HMRC. Three days later, its 99% shareholder Andrew Woosnam bought the assets through PGGBR Ltd, promising a staggered payment plan while dangling an all‑expenses‑paid staff trip to Las Vegas.Asset Buy‑Back and the Vegas IncentiveThe new entity announced a “END OF YEAR TRIP 2026” on LinkedIn, positioning the incentive as a driver for sales targets. However, administrators now report missed instalments and a shortfall in the agreed cash flow.The Money Trail: Debt, Loans and Promised PaymentsInitial cash outlay: £10,000Planned instalments: £25,000 per month for two years, totalling £600,000Outstanding director’s loan from the defunct firm: £1.2mDividends extracted since 2022: almost £2mCompeting bid rejected: £321,000 cash plus an estimated royalty of £110,000Regulatory and Taxpayer Implications of PhoenixismThe case highlights criticism of “phoenixism”, where directors shed liabilities while retaining assets. HMRC estimates that phoenix activities account for about 22% of the £3.8bn tax losses reported in 2022‑2023, raising questions about the adequacy of current safeguards.Outlook: Recovery Prospects and Potential Policy ResponseAdministrators cite a fixed charge against Woosnam’s matrimonial property and a standing order payment, suggesting eventual recovery. Nonetheless, the missed payments and the high‑profile Vegas promise may prompt tighter scrutiny of phoenix transactions and stronger creditor protections.

The Rise of Nigeria's Digital Herbal Marketplace In Abuja, Nigeria, Oke Bola thought a fertility supplement she found online might help her conceive. Instead, within days of taking it, she struggled to breathe. Her experience reflects a growing online trade in unverified herbal remedies promoted across social media platforms. Bola, who is in her early 40s and has never had children, bought the supplement earlier this year and increased the recommended dosage, hoping for quicker results after hearing about it from friends and family. "I recognised the symptoms of asthma; the wheezing sound at night was familiar," she told Al Jazeera. "When I checked online, I realised it could be from the herbal medication." Her experience is not isolated. Across Nigeria, doctors and pharmacists report a surge in social media-driven self-medication, particularly involving unverified herbal products. This trend is worsening health outcomes, delaying treatment, and adding pressure to an already strained healthcare system serving about 230 million people. Nigeria's young, hyperconnected population increasingly uses digital platforms for health information and advice. But that access has also created what Dr Isaac Kolawole and Dr Fidelis describe as an "algorithmic apothecary" – an unregulated online marketplace where influencers and anonymous sellers promote remedies directly to consumers with little or no scientific backing. Health Impacts of Unverified Herbal Remedies Within this ecosystem, herbal remedies, long part of Nigeria's medical and cultural landscape, are increasingly repackaged as miracle cures, sometimes with dangerous consequences. Doctors report more patients arriving at hospitals only when their conditions have significantly worsened, often after prolonged use of unverified treatments. A consultant nephrologist at the University College Hospital in Ibadan, Dr Yemi Raji, said herbal medicine continues to play a role in kidney disease cases in Nigeria. "When you take herbal medication, you are taking both the good and the bad," he said. "Patients often arrive late, when treatment is more difficult and expensive." Dialysis alone can cost between 50,000 and 100,000 naira ($36-72) per session, several times a week. Studies link herbal use to kidney and liver disease cases across Africa, including findings that about 46 percent of liver disease admissions in one Nigerian hospital involved herbs or roots. A 2022 study found that 76.65 percent of participants had used herbal medicine, with more than a third combining herbal and conventional treatments while 82.44 percent did not inform their doctors. The Algorithmic Amplification Effect On a smartphone screen, relief is just a click away: fertility tonics, eye drops promising restored vision, syrups claiming to "flush out" disease. The advertisements are polished, persuasive and constant, woven into TikTok, Facebook, Instagram and X feeds. "The platforms themselves amplify this effect," said Dr Egemba Chinonso Fidelis, a public health advocate known online as Aproko Doctor. "Their algorithms reward engaging content and push it to wider audiences." Even users who try to avoid such content often encounter it repeatedly, shaped by emotional storytelling, music and urgency-driven messaging. A 2025 Nigeria-based study on Jinja Herbal Mixture found it appeared safe for short-term use within tested dosage ranges, but researchers recorded biochemical changes at higher doses, including altered creatinine and sodium levels in test subjects, signs of possible kidney and liver stress. The study called for further research into long-term effects and interactions with conventional medicines. Regulatory Challenges in the Digital Age The National Agency for Food and Drug Administration and Control (NAFDAC) says it is working to track unregistered manufacturers, but enforcement remains difficult, especially online. "With the sheer volume of products online, enforcement has limited reach," said Isaac Kolawole, the southwest zonal director of NAFDAC. Many sellers use fake or incomplete addresses, making them difficult to trace. NAFDAC requires strict registration, testing and approval before herbal products can be sold or advertised, but regulation has not kept pace with online commerce. Fidelis argued that stronger regulation alone is not enough. "If there are no consequences for lying about healthcare online, people will keep doing it," he said. He noted that scammers have even used AI-generated versions of his image to promote fake products. "Real medicine does not promise to cure everything, and it does not rely on countdowns," he added. "Scammers do." Path Forward for Safer Digital Health As Nigeria's digital economy expands, the intersection of technology and healthcare will only grow more complex. Fidelis stressed that access to affordable healthcare must improve, public trust must be rebuilt, and digital platforms must take responsibility for the health content they amplify. Pharmacist Akinade Akinlolu noted that while conditions like diabetes and hypertension can be managed, online claims often suggest cures. "Economic pressure is also pushing people towards cheaper or 'miracle' alternatives," he added. "Without stronger safeguards," Fidelis warned, "the algorithmic apothecary will continue to grow and put more people at risk." The challenge for Nigeria's healthcare system is to harness the power of digital platforms while ensuring they promote evidence-based care rather than potentially harmful alternatives.

The Government's Response to the Youth Employment CrisisA former chief executive of Marks & Spencer has been appointed as a government jobs adviser in its latest attempt to tackle the growing youth unemployment crisis. Marc Bolland, who oversaw the retail chain from 2010 to 2016, will lead a summit of business leaders, amid warnings that the country risks a "lost generation" without urgent intervention.The Scale of the Youth Unemployment ChallengeAbout 1 million people aged 16 to 24 – about one in eight – are not in education, employment or training. An interim report published by the former health secretary Alan Milburn warned that this cohort – known as Neets – could increase to 1.25 million by the 2030s without radical action. The proportion of Neets in the UK is significantly higher than in many other developed countries. In the Netherlands, about 5% of 16 to 24-year-olds are not in education or work, while it is about 12.5% in Britain.Bolland's Role and StrategyIn light of Milburn's findings, Bolland has been appointed as lead non-executive director at the Department for Work and Pensions (DWP), Downing Street said. Bolland, who also led supermarket Morrisons, is understood to have been chosen for the role thanks to his existing involvement with the DWP via his charity Movement to Work. The government said a collaboration with Movement to Work had already helped more than 200,000 unemployed young people find jobs.Economic Impact of Youth UnemploymentThe economic cost of the crisis is estimated to be about £125bn. Milburn's report found that six in 10 young people have never had a job, compared with four in 10 in 2005. He said that an increasing number of young people were being ruled as unfit to work due to health conditions including anxiety, depression and neurodevelopmental conditions. However, it is estimated that for every £25 the government spends on benefits for young people, it devotes just £1 to helping them find work.Focus on Vulnerable GroupsA central part of Bolland's role will be to work with charities supporting disabled young people to ensure they have access to training and employment opportunities. Almost half of those who claim a health or disability benefit before the age of 24 are still unemployed or not in education a decade later.Future Outlook and CollaborationThe government said Bolland would work with "leading chief executives across sectors" to "create clear routes into work and tackle the longstanding challenge of youth unemployment." It added that he would also advise the work and pensions secretary, Pat McFadden, on how the government should respond to Milburn's findings. McFadden said that Bolland's appointment sent a "clear signal" that the government was "serious about tackling that challenge" of youth unemployment. Bolland said he was "honoured and passionate" about working with the government, adding: "I know that working hand in hand with business to support young people gives them the best possible chance of success."

The Lead: A Darkly Bright Review of Shaffer’s FarceThe Guardian’s latest stage review celebrates the Orange Tree Theatre’s revival of Peter Shaffer’s *Black Comedy*, highlighting how the production’s inventive lighting turns darkness into the show’s main character.Lighting as the Star: How the Play Turns Darkness into ComedyInspired by a Chinese‑theatre lamp gag, the production stages a power cut with blinding brightness to represent total darkness, and vice‑versa. When a match is struck the lights dim; a switch flicked on triggers an instant blackout, forcing actors to navigate the tiny stage blind and then stumble about as if they can’t see each other while the audience watches the chaos unfold.Key Production DetailsVenue: Orange Tree Theatre, Richmond, LondonRun: Until 11 July 2026Director: Caroline SteinbeisLighting Designer: Elliot GriggsPhysical Comedy Consultant: John NicholsonCritical Reception and Box‑Office SnapshotWhile the review does not provide hard numbers, the production’s limited 75‑minute run and its pairing with the Menier Chocolate Factory revival of *Equus* suggest a strategic centenary push that is likely to attract both Shaffer enthusiasts and farce lovers, bolstering ticket sales during the summer season.Reviving Shaffer: The Play’s Relevance in Modern TheatreThe piece, set in a post‑World‑War‑II context, unintentionally resonates with today’s fragile power‑supply anxieties. Historical touches—Directory Enquiries, antique fuse boxes, and two “comedy Germans”—are balanced by contemporary direction, such as a Caribbean‑styled cleaning‑lady routine that updates Maggie Smith’s original mockney lines.Looking Ahead: The Future of Farce on Post‑Pandemic StagesWith *Black Comedy* proving its staying power alongside the high‑brow *Equus*, the Guardian predicts a renewed appetite for technically inventive farces that blend physical comedy with modern staging tricks. Directors may increasingly lean on lighting and set design to create immersive, laugh‑inducing spectacles that compensate for smaller venue capacities.

The LeadCorridors have long been more than just passageways in cinema—they are narrative spaces that build tension, create atmosphere, and advance storytelling. The Guardian has compiled a definitive ranking of the 20 most memorable corridors in film history, showcasing how these seemingly simple spaces have become iconic elements of cinematic language.The Art of Cinematic CorridorsFrom the claustrophobic hallways of horror films to the dystopian passageways of science fiction, corridors have served as powerful storytelling devices across genres. The ranking includes entries from 1979 to 2011, with films like "The Thing" (1982), "Brazil" (1985), and "The Raid: Redemption" (2011) demonstrating how directors use these spaces to create memorable sequences.Ranking Criteria and Notable MentionsThe selection process appears to prioritize corridors that have become iconic through their visual impact, narrative significance, and ability to evoke emotion. Notable mentions include:The marble corridor in "Phantasm" (1979), which became a source of nightmares for viewersThe endless grey passageway in "Brazil" (1985), created using forced perspective in a disused flour millThe baroque corridors of "Last Year at Marienbad" (1961), which create a uniquely spooky ambienceThe modern corridor chase in "The Red Queen Kills Seven Times" (1972), featuring a figure in a red cloakThe Impact of Corridors on FilmmakingThese cinematic corridors have influenced generations of filmmakers and continue to be referenced in contemporary cinema. The ranking reveals how directors have mastered the use of confined spaces to build suspense, create visual symbolism, and advance character development. Horror filmmakers, in particular, have long recognized the corridor's potential for terror, using its linear nature to create anticipation and dread.The Future of Corridor Scenes in CinemaAs filmmaking techniques evolve, the corridor continues to be a vital space for cinematic storytelling. With advances in virtual production and immersive technologies, future corridor scenes may push the boundaries of visual storytelling even further. The enduring appeal of these spaces suggests that corridors will remain essential tools for filmmakers seeking to create memorable, tension-filled sequences that resonate with audiences.

The Collaboration Behind 'Fairyland' Sofia Coppola and Andrew Durham are no strangers to each other. They've worked together on various projects, including Coppola's TV show 'Hi-Octane' and her short film 'Lick the Star'. So when Coppola optioned Alysia Abbott's memoir 'Fairyland: A Memoir of My Father', she knew Durham would be the perfect director for the film. Personal Connections to the Story Both Coppola and Durham have personal connections to the story. Durham grew up in the Bay Area of San Francisco in the 1970s with a gay dad, Jerry, who died of AIDS in 1992. Coppola's own experiences growing up with a famous father, Francis Ford Coppola, also inform her perspective on the film. The Film's Themes and Inspiration The film explores themes of family, identity, and coming-of-age. It's a bittersweet father-daughter story that continues a pattern in Coppola's filmography. Durham notes that he and Coppola share a similar sensibility and taste, which made her the perfect producer for the film. The Future of 'Fairyland' 'Fairyland' is set to release in cinemas on May 29. With its talented cast, including Emilia Jones and Scoot McNairy, and its unique perspective on the LGBTQ+ experience, the film is sure to resonate with audiences. As Coppola says, it's in the tradition of championing things you love and believe in – just like her father did at his production company, Zoetrope.